- Fee assured
- Awaiting verification
- Inflammatory bowel disease
Dr Amar Sharif graduated in 1997, Royal Free Hospital School of Medicine, London with Distinction in Medicine, Surgery and Clinical Pharmacology/Therapeutics and was awarded Dean’s Medal in Clinical Medicine, ED Blunt Prize in Clinical Medicine, Willliam Marsden Scholarship and Medal.
His early medical training was at the prestigious Academic Department of Medicine, Royal Free Hampstead NHS Trust and North West London NHS Hospitals. As a Specialist Registrar, he trained on the North West Thames rotation, working at St. Mary’s, Hammersmith, Chelsea and Westminster and Central Middlesex Hospitals.
In 2007 he was awarded MD research degree at Imperial College London, Hammersmith Campus and has published work in genetic and molecular aspects of bile duct cancers. He currently works as a Consultant Gastroenterologist and Physician at Central Middlesex Hospital.
Areas of interest
Alcoholic Liver Disease; Cirrhosis of the Liver; Cholangiocarcinoma
Bile duct cancers
Esther Frances White Memorial Prize for:
Distinction in Medicine
Distinction in Surgery
Distinction in Clinical Pharmacology and Therapeutics
Dean’s Medal for Skill in Clinical Medicine
ED Blunt Prize in Clinical Medicine
Merit in Population and Health Care Sciences
Commendation in Clinical Pharmacology and Therapeutics
Sharif A, Taylor-Robinson SD, Williams HRT, Lampejo T, Khan S, Thillainayagam AV, Westaby D, Thomas HC, Cox IJ. Metabolic Profiling of Bile in Cholangiocarcinoma Using In Vitro Magnetic Resonance Spectroscopy. HPB; International Hepato-Pancreato-Biliary Association. 2010; 12(6); 396-402
Sharif A, Khan SA, Lindley CM, Lampejo TL, Goldin RD, Cox IJ, Taylor-Robinson SD. Cholangiocarcinoma. In: Liver: A Complete Book on Hepato-Pancreato-Biliary Diseases (Al-Mahtab M and Rahman S, Eds), Elsevier, Noida 2009, Chapter 66 p596-607 ISBN:978-81-312-1674-3.
Khan SA, Goldin RD, Sharif A,, Habib N. Histopathology and Molecular Pathogenesis of Biliary Tract Cancer. Biliary Tract and Gallbladder Cancer: Diagnosis & Therapy, Charles R. Thomas, Jr. and Clifton David Fuller (Eds) Demos Medical Publishing. 2009.
Sharif A; Al-Gazzar A; Wang YQ; Griffiths W; Jane C; Simon TR. Proteomic analysis of intrahepatic cholangiocarcinoma. 57th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases. 44:527A-527A. (Oct 2006).
Wang Y, Al-Gazzar A, Seibert C, Sharif A, Lane C, Griffiths WJ. Proteomic analysis of cytochromes P450: a mass spectrometry approach. Biochem Soc Trans. 2006:1246-51.
Wang Y; Al-Gazzar A; Seibert C; Sharif A; Lane C; Griffiths WJ. Proteomic analysis of cytochromes P450: a mass spectrometry approach. 8th International Symposium on Cytochrome P450 Biodiversity and Biotechnology. 34:1246-1251. (Dec 2006).
Cox IJ, Sharif A, Cobbold JF, Thomas HC, Taylor-Robinson SD. Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease. World J Gastroenterol. 2006;12:4773-4783.
- MBBS (Hons) Royal Free Hospital of School of Medicine 1997
- MRCP Royal College of Physicians 2000
- MD Imperial College London 2007
Details of entry to specialist register
- CCST, Gastroenterology and General Internal Medicine, 2009
Affiliations / memberships
British Soceity of Gastroenterology
British Association of Liver
- BMI The Clementine Churchill Hospital, HA1 3RX
- 14:00 - 17:00
- 01895 628885
- Central Middlesex HospitalActon LaneLONDON
- 14:00 - 17:00
- 020 8453 2364
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details